Selank before and after reports read differently from the ones attached to every other compound on a site like this. Nobody posts photographs. What people describe is internal: less edgy in the afternoon, less churn at bedtime, an easier week under the same pressure. That is the hardest category of change there is to verify, and it is the only category anyone claims.
The vendor we point lifters to
Selank from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
The published certificate for lot 29-01260229 assays this vial at 12.29 mg against a 10 mg label, and reports no endotoxin or sterility testing. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Two independent lab reports per batch
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified August 21, 2026.
There is a reason for that shape. This peptide was developed in Russia as an anxiolytic, and the entire research programme behind it points at anxiety, not at physique. No study in any species has measured muscle mass, strength, body fat or training output after administering it. A before and after showing body composition does not exist because the question was never asked.
Subjective change is not a lesser claim, it is a harder one
Saying a result is subjective is not the same as saying it is imaginary. Anxiety is real, it responds to treatment, and self report is the primary instrument used to measure it in clinical practice everywhere.
The problem is that self reported internal states are the outcomes most sensitive to expectation. Someone who has researched a compound, paid for it, and started using it deliberately has three separate reasons to notice improvement, and none of them requires the substance to do anything. Mood also has strong natural variation. A bad month often ends on its own, and whatever was started at the low point receives the credit.
This is precisely why controlled trials with blinding exist for anxiolytics, and why the comparison group in those trials is not "nothing". It is an identical looking treatment the participant cannot distinguish from the real one.
What a Selank before and after can actually record
| What gets reported | What it can establish | What it cannot establish | Organism |
|---|---|---|---|
| Feeling calmer in week two | That the person felt calmer | That the peptide caused it | Human, uncontrolled |
| Better sleep onset | A perceived change in sleep | Change in measured sleep architecture | Human, uncontrolled |
| Fewer skipped training sessions | An adherence change | A physiological effect on training capacity | Human, uncontrolled |
| A validated anxiety questionnaire pair | A change in score | Attribution without a control group | Human, uncontrolled |
| Change in scale weight or waist | That weight moved | Any link to this peptide, since none has been studied | None |
| Russian clinical trial data | Clinical effect within one regulatory system | A result the Western evidence system has reviewed | Human |
The fifth row is the important one for this audience. There is no body composition column to fill in, in any species.
Why blinding matters more here than for anything visible
Placebo response is not uniform across outcome types. It is largest where the outcome is a self reported internal state, and smallest where the measurement is independent of the person being measured.
Anxiety, mood, sleep quality and a sense of resilience under pressure sit at the extreme end of that spectrum. They are also the entire outcome list for this peptide. A compound whose only reported effects are the ones most responsive to expectation is a compound whose personal reports carry the least evidential weight, however sincerely they are given.
That is not an argument that it does nothing. Russian clinical research in patients with anxiety disorders has reported symptom improvement, and controlled clinical work is the right way to settle a question of this kind. It is an argument that a person's own before and after cannot settle it, because the design that separates a real effect from an expected one is precisely what a personal trial lacks.
Two evidence systems, one compound
The regulatory position is genuinely unusual, and both halves of it get misrepresented depending on who is talking.
Selank is a registered medicine in Russia. It has been through that country's approval process, it is prescribed there, and there is real clinical literature behind it in patients with anxiety disorders, including work comparing it against benzodiazepine treatment. Dismissing all of that as nonexistent is simply inaccurate, and people do it routinely because the studies are unfamiliar and mostly not in English.
At the same time, it holds no authorisation from the FDA, the EMA or the MHRA, and there is no genuine registered Western trial of it. Searches of Western trial registries return records that mention the term without studying the compound: epilepsy drug studies, transcranial stimulation for dyslexia, telephone psychotherapy for depression, neurofeedback, balance training. Reading the titles rather than counting the hits reduces the list to nothing. Anyone citing a trial number for this peptide has counted false matches.
Both statements are true simultaneously. Real clinical use and regulatory approval in one jurisdiction, and complete absence from the evidence system most readers of this site implicitly trust.
The body composition question, answered directly
No study in any organism has measured lean mass after Selank administration. None has measured strength, power, endurance, body fat, muscle protein synthesis or anything touching the myostatin pathway. There is no positive finding here and no negative finding either, because the measurement has never been made.
What the animal literature does contain is neurochemistry. Rat studies have reported effects on brain serotonin metabolism and on expression of brain derived neurotrophic factor. Work in human blood plasma has described slowed breakdown of endogenous enkephalins, which is the kind of mechanistic result that explains an anxiolytic profile rather than a physique one.
That is the whole picture. Anyone constructing a lean mass argument from it is building on nothing, and on this site in particular that construction is worth naming when it appears.
The indirect route, and exactly how far it goes
There is one honest reason a lifter might take an interest, and it should be stated at its real strength rather than inflated.
Training results come from accumulated sessions over years, and the things that break that accumulation are frequently not physical. Poor sleep, chronic stress and anxiety degrade adherence, appetite regulation and recovery in humans as a general matter. Someone who trains through an anxious, badly slept quarter usually trains worse and less often, and that lost work shows up eventually in body composition. So a treatment that genuinely improved anxiety could, in principle, protect training continuity.
Now the limits, which are severe. That chain has never been tested for this compound in any species. No study has followed people using it and measured training adherence, session quality, recovery, or any body composition endpoint. The anxiolytic research measures anxiety symptoms in patients with anxiety disorders, which is a clinical population and a clinical question, not a lifter looking for an edge.
It is a plausible chain and an unevidenced one. That is a legitimate thing to say, and it is very different from saying the peptide supports lean mass.
What the reports are usually tracking
Read enough of them and a pattern appears. The changes described are almost never physical: fewer racing thoughts at bedtime, less irritation in the afternoon, an easier time starting a session that would otherwise have been skipped.
Those are real experiences, and they are also what a change in routine produces on its own. Someone starting a compound typically also starts paying attention: going to bed earlier because they want a clean test, cutting back on alcohol, taking training seriously again for a few weeks. Any one of those changes sleep and mood in humans without any pharmacology involved.
The useful discipline is to ask what else began in the same week. It usually turns out the vial was one of four things that changed, and the only one that cost money.
Questions people bring to a transformation thread
Are there published before and after body composition results for Selank?
No. No study in any species has used body composition as an outcome, so no such result exists to publish.
Does the Russian clinical data show anything about muscle?
No. That literature concerns anxiety disorders and related conditions in patients, and it does not measure muscle, strength or body fat.
If someone feels better and trains harder, does that count?
It counts for that person and it is not evidence about the compound. Feeling better and training harder are exactly the outcomes expectation produces on its own, which is why controlled comparison exists.
Are there Western trials in progress?
None. Registry searches return unrelated studies that happen to mention the term, and reading the records leaves no Selank trial at all.
Why do the reports never include photographs?
Because the reported effects are internal states. Nobody claims a visible change, which is the most honest feature of this compound's anecdotal record.
Is it approved anywhere?
It is a registered medicine in Russia. It has no authorisation from the FDA, the EMA or the MHRA, and outside Russia it is sold as a research chemical with contents attested only by the seller.